AB SCIENCE S.A.
Climate Impact & Sustainability Data (2016)
Reporting Period: 2016
Environmental Metrics
ESG Focus Areas
- Social
- Environmental
- Governance
Social Achievements
- Implemented a new three-year plan on professional equality between men and women.
- Fulfilled its obligation to employ disabled workers.
Governance Achievements
- Established a finance committee, a compensation and nominations committee, and a scientific committee.
Climate Goals & Targets
Environmental Challenges
- Suspension of masitinib authorization in the US for canine mastocytoma.
- Rapidly evolving regulatory environment in the pharmaceutical industry.
- Intense competition in the research and development of tyrosine kinase inhibitors.
- Pressure on pricing and reimbursement of medications.
- Dependence on third-party manufacturers and suppliers.
- Need for significant funding to continue clinical trials.
- Risk of failure or delay in product development.
- Dependence on key personnel.
- Managing internal growth.
- Potential for legal and regulatory risks related to patents and product liability.
Mitigation Strategies
- Equity lines with Société Générale and Crédit Agricole.
- Strict adherence to regulations and good practices in clinical trials.
- Continuous monitoring and quality control of data.
- Careful selection and monitoring of third-party suppliers and manufacturers.
- Implementation of procedures to prevent corruption.
- Focus on drug discovery and internal development of clinical expertise.
- Use of futility analysis, adaptive design, and resampling options in clinical trials.